Metoclopramide Tablets — Class II drug recall D-0038-2027
Ongoing recall by Teva Pharmaceuticals USA, Inc, reported 2026-10-21, distributed nationwide. Presence of Foreign Tablets/Capsules
| Recall number | D-0038-2027 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | Teva Pharmaceuticals USA, Inc, Parsippany, NJ, United States |
| Recall initiated | 2026-09-29 |
| Classified | 2026-10-13 |
| Reported by FDA | 2026-10-21 |
| Distributed | Nationwide (US) |
| Quantity | 240,448 cartons |
| NDC | 00093-2203, 00093-2203-01, 00093-2203-05, 00093-2203-10, 00093-2204, 00093-2204-01, 00093-2204-05 |
| Lot numbers | 8633085, 8634085, 8635085, 8636085 |
| Expiration dates | 2027-07 |
Product
Metoclopramide Tablets, USP, 5 mg, [100 or 500] Tablets per bottle, Rx Only, Manufactured for: Teva Pharmaceuticals, Parsippany, NJ 07054. NDC 100 Tablets: 0093-2204-01; NDC 500 Tablets: 0093-2204-05
Reason for recall
Presence of Foreign Tablets/Capsules
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0038-2027. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-10-27. Not affiliated with or endorsed by FDA. Not medical or legal advice.